iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.

iAnthus Capital Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

Curaleaf Holdings, Inc.

iAnthus Capital Holdings, Inc. operates as a cannabis company focusing on vertically integrated operations including cultivation, processing, and retailing across multiple states in the U.S.

Metric
Company Name	iAnthus Capital Holdings, Inc.	Curaleaf Holdings, Inc.
Symbol	IAN	CURA
MSH ID	COM:IANTHUS	COM:CURALEAF
Market	STOCKS	STOCKS
Sector	Healthcare	Healthcare
Industry	Drug Manufacturers - Specialty & Generic	Drug Manufacturers - Specialty & Generic
Country	US	US
Stage
Employee Count	717	5.65K
Website	ianthus.com	curaleaf.com
LinkedIn
Founders

Metric
Market Cap	94.62M	2.73B
Enterprise Value
Monthly Web Traffic		2.08M
Web Traffic Growth		-0.40
Valuation
Raised Capital

Metric
Revenue	159.24M	1.82B
Revenue (LTM)
Revenue (NTM)
Gross Profit	63.17M	644.70M
EBITDA	-14K	343.90M
Operating Income	-40.71M	57.88M
Net Income	-76.62M	-379.53M
EPS	-0.01	-0.52
Diluted EPS	-0.01	-0.52
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.43	0.38
Operating Profit Margin	-0.17	0.04
EBITDA Margin	-0.00	0.19
Net Profit Margin	-0.37	-0.19
Return on Equity	6.51	-0.25
Return on Assets	-0.23	-0.09
Return on Capital Employed	-0.18	0.02

COM:IANTHUS

iAnthus Capital Holdings, Inc.

Last Close

0.01

20/11 15:26

Market Cap

132.31M

Beta: -

Volume Today

500

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-1.45	-6.35
P/B Ratio	-3.56	1.71
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.91	1.37
EV Multiple	482.28	4.89

Metric
Days Sales Outstanding	11.35	18.73
Days Payables Outstanding	67.71	30.85
Days Inventory Outstanding	130.52	90.60
Operating Cycle	141.87	109.33
Cash Conversion Cycle	74.16	78.48
Asset Turnover	0.62	0.56

Metric
Operating Cash Flow	3.02M	101.58M
Free Cash Flow	-3.06M	6.69M
Cash Flow to Debt	0.04	0.18
Operating Cash Flow/Sales	0.05	0.09
Free Cash Flow Yield	-0.05	0.02

Metric
Cash & Equivalents	13.10M	121.07M
Accounts Receivable	-828K	148.47K
Inventory	25.38M	284.70M
Goodwill		826.27M
Debt to Capitalization	1.68	0.46
Debt to Assets	0.67	0.20
Current Ratio	0.41	0.72
Quick Ratio	0.23	0.50

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04	0.01
R&D to Revenue
SG&A to Revenue	0.43	0.21